Acer Therapeutics Inc. (ACER)
New data for Roches Vabysmo reinforce its efficacy, safety and durability in neovascular or “wet” age-related macular degeneration (nAMD)
New data for Roches Vabysmo reinforce its efficacy, safety and durability in neovascular or “wet” age-related macular degeneration (nAMD)
There are no comments here yet...